A Study to Evaluate the Efficacy and Safety of DA-5204
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group
clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the
non-inferiority of DA-5204 compared with Stillen® tab. in patients with acute or chronic
gastritis.